COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 14.29
(0.0%)
CNY 14.29
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.87 Billion CNY | -34.01% |
| 2022 | 2.83 Billion CNY | 133.21% |
| 2021 | 1.21 Billion CNY | 67.93% |
| 2020 | 723.25 Million CNY | -71.14% |
| 2019 | 2.5 Billion CNY | 6905.37% |
| 2018 | -36.82 Million CNY | 77.5% |
| 2017 | -163.61 Million CNY | -115.7% |
| 2016 | -75.85 Million CNY | 68.57% |
| 2015 | -241.35 Million CNY | -302.42% |
| 2014 | -59.97 Million CNY | 34.02% |
| 2013 | -90.89 Million CNY | -544.1% |
| 2012 | 20.46 Million CNY | -75.37% |
| 2011 | 83.09 Million CNY | 1.06% |
| 2010 | 82.22 Million CNY | -20.78% |
| 2009 | 103.79 Million CNY | -6.21% |
| 2008 | 110.67 Million CNY | 43.42% |
| 2007 | 77.16 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.04 Billion CNY | -42.69% |
| 2024 Q1 | -729.35 Million CNY | 95.25% |
| 2024 Q3 | 137.45 Million CNY | 113.21% |
| 2023 FY | 1.86 Billion CNY | -34.01% |
| 2023 Q3 | 2.02 Million CNY | -99.73% |
| 2023 Q4 | -15.35 Billion CNY | -759335.84% |
| 2023 Q2 | 741.21 Million CNY | -6.6% |
| 2023 Q1 | 793.56 Million CNY | 27.87% |
| 2022 Q4 | 620.62 Million CNY | -62.16% |
| 2022 Q3 | 1.64 Billion CNY | 1103.21% |
| 2022 Q2 | 136.32 Million CNY | 106.34% |
| 2022 Q1 | -2.14 Billion CNY | -516.58% |
| 2022 FY | 2.83 Billion CNY | 133.21% |
| 2021 FY | 1.21 Billion CNY | 67.93% |
| 2021 Q4 | 516.01 Million CNY | -12.05% |
| 2021 Q2 | 811.15 Million CNY | 119.81% |
| 2021 Q1 | 369.02 Million CNY | 116.33% |
| 2021 Q3 | 586.73 Million CNY | -27.67% |
| 2020 FY | 723.25 Million CNY | -71.14% |
| 2020 Q3 | 728.9 Million CNY | -1.65% |
| 2020 Q2 | 741.11 Million CNY | 138.32% |
| 2020 Q1 | 310.98 Million CNY | 2011.69% |
| 2020 Q4 | 170.58 Million CNY | -76.6% |
| 2019 Q3 | 362.93 Million CNY | 8.08% |
| 2019 FY | 2.5 Billion CNY | 6905.37% |
| 2019 Q1 | 641.37 Million CNY | 1520.92% |
| 2019 Q2 | 335.79 Million CNY | -47.64% |
| 2019 Q4 | -16.26 Million CNY | -104.48% |
| 2018 FY | -36.82 Million CNY | 77.5% |
| 2018 Q4 | -45.13 Million CNY | -79.48% |
| 2018 Q3 | -25.14 Million CNY | -17.98% |
| 2018 Q2 | -21.31 Million CNY | 37.04% |
| 2018 Q1 | -33.85 Million CNY | 67.58% |
| 2017 Q4 | -104.44 Million CNY | -110.51% |
| 2017 FY | -163.61 Million CNY | -115.7% |
| 2017 Q1 | -39.72 Million CNY | -224.84% |
| 2017 Q2 | -62.57 Million CNY | -57.54% |
| 2017 Q3 | -49.61 Million CNY | 20.72% |
| 2016 Q2 | -29.23 Million CNY | 17.37% |
| 2016 FY | -75.85 Million CNY | 68.57% |
| 2016 Q4 | 31.81 Million CNY | 173.91% |
| 2016 Q3 | -43.05 Million CNY | -47.26% |
| 2016 Q1 | -35.38 Million CNY | 76.72% |
| 2015 FY | -241.35 Million CNY | -302.42% |
| 2015 Q1 | -14.97 Million CNY | 50.93% |
| 2015 Q2 | -14.7 Million CNY | 1.75% |
| 2015 Q3 | -59.71 Million CNY | -305.97% |
| 2015 Q4 | -151.95 Million CNY | -154.49% |
| 2014 Q2 | -3.41 Million CNY | 74.12% |
| 2014 FY | -59.97 Million CNY | 34.02% |
| 2014 Q3 | -12.83 Million CNY | -275.31% |
| 2014 Q1 | -13.21 Million CNY | 67.77% |
| 2014 Q4 | -30.5 Million CNY | -137.77% |
| 2013 Q2 | -12.93 Million CNY | 46.2% |
| 2013 Q1 | -24.03 Million CNY | -399.34% |
| 2013 FY | -90.89 Million CNY | -544.1% |
| 2013 Q4 | -40.98 Million CNY | -216.77% |
| 2013 Q3 | -12.93 Million CNY | -0.04% |
| 2012 Q2 | -911.65 Thousand CNY | -111.6% |
| 2012 FY | 20.46 Million CNY | -75.37% |
| 2012 Q4 | 8.03 Million CNY | 46.22% |
| 2012 Q3 | 5.49 Million CNY | 702.45% |
| 2012 Q1 | 7.85 Million CNY | -71.96% |
| 2011 Q2 | 43.59 Million CNY | 753.99% |
| 2011 Q1 | 5.1 Million CNY | -86.38% |
| 2011 FY | 83.09 Million CNY | 1.06% |
| 2011 Q3 | 6.37 Million CNY | -85.38% |
| 2011 Q4 | 28.02 Million CNY | 339.8% |
| 2010 FY | 82.22 Million CNY | -20.78% |
| 2010 Q1 | 30.1 Million CNY | 21.16% |
| 2010 Q2 | 9.69 Million CNY | -67.79% |
| 2010 Q3 | 4.94 Million CNY | -48.99% |
| 2010 Q4 | 37.46 Million CNY | 657.27% |
| 2009 Q3 | 30.9 Million CNY | 32.93% |
| 2009 Q1 | 24.8 Million CNY | 0.0% |
| 2009 Q2 | 23.24 Million CNY | -6.28% |
| 2009 FY | 103.79 Million CNY | -6.21% |
| 2009 Q4 | 24.84 Million CNY | -19.58% |
| 2008 FY | 110.67 Million CNY | 43.42% |
| 2007 FY | 77.16 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 1.21 Billion CNY | -53.79% |